GeneDx Holdings Corp. Operating Cash Flow
GeneDx Holdings Corp. (WGS) reported Operating Cash Flow of -$61.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-03
- GeneDx Holdings Corp. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$28.98M, a 378.13% decline year-over-year.
- GeneDx Holdings Corp. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$32.41M, a 418.29% decline year-over-year.
- GeneDx Holdings Corp. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.09M.
- GeneDx Holdings Corp. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $15.77M.
- GeneDx Holdings Corp. net cash provided by (used in) operating activities for fiscal 2025 was $33.28M.
- GeneDx Holdings Corp. net cash provided by (used in) operating activities for fiscal 2024 was -$28.50M.
- GeneDx Holdings Corp. net cash provided by (used in) operating activities for fiscal 2023 was -$180.15M.
- GeneDx Holdings Corp. net cash provided by (used in) operating activities for fiscal 2022 was -$319.15M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$28.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$61.39M 10-Q · filed 2026-08-03 | -$64.48M derived: sum of 3 quarters · filed 2026-08-03 | -$48.71M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | -$32.41M 10-Q · filed 2026-05-04 | -$35.50M derived: sum of 2 quarters · filed 2026-05-04 | -$19.73M derived: sum of 3 quarters · filed 2026-05-04 | -$9.31M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | -$3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $12.68M derived: sum of 2 quarters · filed 2026-02-23 | $23.10M derived: sum of 3 quarters · filed 2026-08-03 | $33.28M 10-K · filed 2026-02-23 | ||
| 2025-09-30 | $15.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $26.19M derived: sum of 2 quarters · filed 2026-08-03 | $36.37M 10-Q · filed 2025-10-28 | $33.19M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $10.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $20.60M 10-Q · filed 2026-08-03 | $17.42M derived: sum of 3 quarters · filed 2026-08-03 | $13.02M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | $10.18M 10-Q · filed 2026-05-04 | $7.00M derived: sum of 2 quarters · filed 2026-05-04 | $2.60M derived: sum of 3 quarters · filed 2026-05-04 | -$1.90M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | -$3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$7.58M derived: sum of 2 quarters · filed 2026-02-23 | -$12.08M derived: sum of 3 quarters · filed 2026-02-23 | -$28.50M 10-K · filed 2026-02-23 | ||
| 2024-09-30 | -$4.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$8.90M derived: sum of 2 quarters · filed 2025-10-28 | -$25.31M 10-Q · filed 2025-10-28 | -$55.17M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-06-30 | -$4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$20.92M 10-Q · filed 2025-07-29 | -$50.78M derived: sum of 3 quarters · filed 2026-02-23 | -$92.00M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-03-31 | -$16.41M 10-Q · filed 2025-04-30 | -$46.27M derived: sum of 2 quarters · filed 2026-02-23 | -$87.50M derived: sum of 3 quarters · filed 2026-02-23 | -$141.00M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2023-12-31 | -$29.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$71.09M derived: sum of 2 quarters · filed 2026-02-23 | -$124.59M derived: sum of 3 quarters · filed 2026-02-23 | -$180.15M 10-K · filed 2026-02-23 | ||
| 2023-09-30 | -$41.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$94.73M derived: sum of 2 quarters · filed 2024-10-29 | -$150.29M 10-Q · filed 2024-10-29 | -$214.94M derived: sum of 4 quarters · filed 2024-10-29 | ||
| 2023-06-30 | -$53.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$109.06M 10-Q · filed 2024-07-30 | -$173.72M derived: sum of 3 quarters · filed 2024-07-30 | -$262.08M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2023-03-31 | -$55.56M 10-Q · filed 2024-04-29 | -$120.21M derived: sum of 2 quarters · filed 2024-04-29 | -$208.58M derived: sum of 3 quarters · filed 2024-04-29 | -$293.22M derived: sum of 4 quarters · filed 2024-04-29 | ||
| 2022-12-31 | -$64.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$153.02M derived: sum of 2 quarters · filed 2024-02-23 | -$237.66M derived: sum of 3 quarters · filed 2024-02-23 | -$319.15M 10-K · filed 2024-02-23 | ||
| 2022-09-30 | -$88.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$173.01M derived: sum of 2 quarters · filed 2023-11-03 | -$254.50M 10-Q · filed 2023-11-03 | -$306.49M derived: sum of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | -$84.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$166.14M 10-Q · filed 2023-08-08 | -$218.12M derived: sum of 3 quarters · filed 2023-08-08 | -$289.06M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | -$81.49M 10-Q · filed 2023-05-09 | -$133.48M derived: sum of 2 quarters · filed 2023-05-09 | -$204.42M derived: sum of 3 quarters · filed 2023-05-09 | -$229.72M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | -$51.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$122.92M derived: sum of 2 quarters · filed 2023-03-16 | -$148.23M derived: sum of 3 quarters · filed 2023-03-16 | -$190.43M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | -$70.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$96.24M derived: sum of 2 quarters · filed 2022-11-14 | -$138.45M 10-Q · filed 2022-11-14 | -$138.47M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$25.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$67.51M 10-Q · filed 2022-08-15 | -$926.72K 10-Q · filed 2021-07-21 | -$67.53M derived: sum of 3 quarters · filed 2022-08-15 | -$67.90M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$42.21M 10-Q · filed 2022-05-12 | -$467.27K 10-Q · filed 2021-05-24 | -$42.23M derived: sum of 2 quarters · filed 2022-05-12 | -$42.59M derived: sum of 3 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$20.30K derived: 10-K/A 6 month − 10-Q 3 month · filed 2021-05-05 | -$386.11K 10-K/A · filed 2021-05-05 | -$93.13M 10-K · filed 2023-03-16 | |||
| 2020-09-30 | -$365.81K 10-Q · filed 2020-11-16 | -$74.80M 10-Q · filed 2021-11-15 | ||||
| 2019-12-31 | -$18.73M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |